Pifias

2563 comentarios

  • Enlace al Comentario لیست قیمت بلور کاوه Miércoles, 11 Diciembre 2024 07:57 publicado por لیست قیمت بلور کاوه

    It's an awesome post in support of all the online viewers;
    they will get advantage from it I am sure.

  • Enlace al Comentario ThomasHaw Miércoles, 11 Diciembre 2024 06:46 publicado por ThomasHaw

    soap2day best series soap2day

  • Enlace al Comentario JamesHem Miércoles, 11 Diciembre 2024 05:49 publicado por JamesHem

    РПНУ Лизинг https://rpnu-leasing.ru надежный партнер в лизинге автомобилей, спецтехники и оборудования. Гарантируем отсутствие отказов благодаря индивидуальному подходу к каждому клиенту. Удобные условия и быстрое оформление помогают получить нужное имущество без лишних сложностей.

  • Enlace al Comentario Fysrpz Miércoles, 11 Diciembre 2024 05:29 publicado por Fysrpz

    valif online russian - valif pills starve purchase sinemet

  • Enlace al Comentario onexrussiasite Miércoles, 11 Diciembre 2024 04:54 publicado por onexrussiasite

    Пройдите простую 1xslots регистрацию и начните выигрывать сразу.

  • Enlace al Comentario gold ira companies rated Martes, 10 Diciembre 2024 21:13 publicado por gold ira companies rated

    Regards for helping out, excellent info.

  • Enlace al Comentario http://Freeflashgamesnow.com Martes, 10 Diciembre 2024 20:41 publicado por http://Freeflashgamesnow.com

    Some genuinely nice stuff on this web site,
    I enjoy it.

  • Enlace al Comentario iqos iluma one รีวิว Martes, 10 Diciembre 2024 16:38 publicado por iqos iluma one รีวิว

    PMI's US launch of flagship IQOS device needs FDA green light

    *

    Six health campaign groups wrote letter to FDA criticising PMI Say PMI misrepresented past FDA decisions on IQOS

    *

    PMI says it discusses its products in accordance with law

    *

    FDA acknowledges receiving campaigners' letter

    (Updates headline)

    By Emma Rumney

    LONDON, July 16 (Reuters) - Health campaigners have written to U.S.

    regulators accusing Philip Morris International of misrepresenting
    past regulatory decisions, seeking to disrupt the launch of
    its flagship heated tobacco device IQOS in the United States.


    The world's biggest tobacco company by market value has spent billions of
    dollars developing the product, which investors see as
    key to driving future growth. But it needs permission from the U.S.
    Food and Drug Administration to sell it in the world's second largest tobacco market by revenue.


    Six anti-tobacco and health groups, including the Campaign for Tobacco-Free Kids,
    the American Academy of Pediatrics and the American Lung
    Association, wrote to the FDA to oppose IQOS-related applications PMI has submitted to the agency.


    "PMI has repeatedly made misleading and deceptive statements wrongly suggesting that the FDA has found that IQOS reduces the risk of disease," the letter, dated June 27
    and reviewed by Reuters, said.

    The campaign groups allege that PMI violated the FDA's orders by
    suggesting IQOS offered lower risks than cigarettes.
    Their letter cited four examples of such statements in the United States, the Philippines, Mexico and Kazakhstan.

    They also said in the letter that upcoming independent studies contradict PMI's findings about how many IQOS users completely switch to the device from cigarettes.



    Presentations on the studies from the International Tobacco
    Control Project (ITC) at Canada's University of Waterloo
    are attached to the letter as exhibits.

    They show the ITC found a far lower rate of IQOS users had quit smoking in Japan and Korea than estimates from PMI.


    These factors "directly bear on whether PMI should be permitted to market IQOS" in the United States, the campaigners' letter said.



    The contents of the letter have not been previously reported.


    Asked by Reuters to respond to the letter, a PMI spokesperson said the company was proud to discuss
    the FDA's conclusions on IQOS.

    The spokesperson did not initially address each example but said some
    of the language flagged by campaigners was, in the company's view, compatible with the FDA's orders.
    On Tuesday, the spokesperson added that this was true all of the language
    cited in the campaigners' letter.

    "Wherever we discuss our science and our products, we do so in accordance with all applicable laws," the spokesperson said.



    Reuters could not determine whether the campaigners' letter would change the FDA's approach to IQOS.
    The agency said it had received the letter and would respond directly to the senders.
    It did not comment further.

    Devices like IQOS heat up sticks of ground tobacco without burning them in an attempt to avoid the harmful chemicals released via combustion.

    The FDA first authorised PMI to sell an older version of IQOS in 2019.
    It subsequently authorised the company to market
    it as offering reduced exposure to harmful chemicals versus cigarettes for smokers who completely switch -
    known as an "exposure modification order".

    The FDA can also issue a "risk modification order",
    authorising a company to claim its product reduces the risk of tobacco-related harm and disease.

    But this is harder to prove, especially without long-term, epidemiological studies.



    The FDA rejected PMI's previous application to say its older IQOS device results in reduced health risks, saying there
    wasn't sufficient evidence to support this.

    PMI applied in 2023 to renew its existing exposure
    modification orders. Later that year, it also applied to sell and market a newer version of
    the IQOS device in the same way. The FDA has yet
    to decide on these applications.

    Marketing the product as having health benefits compared to traditional cigarettes could help PMI persuade consumers to switch as well
    as afford it tax benefits versus cigarettes in some U.S.
    states.

    PMI is preparing to sell an older IQOS device in four U.S.
    cities. However, it has said it will not pursue a full U.S.

    launch until the newer version of its device gets FDA
    authorisation.

    SWITCH RATES

    The campaign groups also cited preliminary data from ITC studies in Japan and Korea, saying it contradicted PMI's findings about how many IQOS users completely
    switch from cigarettes.

    The studies have been presented at academic conferences but have not yet been submitted for
    publication in a journal, ITC researchers told Reuters.

    As a result, study abstracts have been peer reviewed but the full findings have yet
    to go through that process.

    Japan is IQOS' largest market and the introduction of heated tobacco there coincided with an accelerated
    decline in cigarette sales.

    PMI estimates more than seven out of 10 of its registered IQOS
    customers globally have quit cigarettes.
    A 2023 PMI application to the FDA emphasised that the majority of IQOS users were using IQOS exclusively.


    However, the ITC's researchers put the percentage of all IQOS
    users that had quit smoking at just 15% in Japan and 30% in Korea in 2021.


    Users most commonly used IQOS and cigarettes
    simultaneously, known as "dual use", often leading to an overall
    increase in tobacco consumption, the ITC researchers found.


    PMI pointed to a 2019 Japanese government health survey, where 75% of respondents who reported using heated tobacco
    said they did not smoke.

    However, a paper published this year, led by researchers from Georgetown University, highlighted flaws in the
    government's survey, including changes to the question format that can lead
    to under-reporting of smoking.

    Other surveys have also found higher rates of dual use than the government,
    it said.

    (Reporting by Emma Rumney; Editing by Matt Scuffham
    and Emelia Sithole-Matarise)

  • Enlace al Comentario recommended options for retirement ira rollover Martes, 10 Diciembre 2024 16:09 publicado por recommended options for retirement ira rollover

    I like this weblog very much, Its a real nice post to read and
    get information.

  • Enlace al Comentario reliable firms for gold ira accounts Martes, 10 Diciembre 2024 15:48 publicado por reliable firms for gold ira accounts

    You're so cool! I do not think I have read through anything like this before.
    So great to discover someone with some original thoughts on this issue.
    Really.. thank you for starting this up. This web site is something that is needed on the internet,
    someone with a little originality!

Deja un comentario

Asegúrese de introducir toda la información requerida, indicada por un asterisco (*). No se permite código HTML.